Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA)

NCT02730923 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Carcinoma
Metastatic Carcinoma
Hormone Receptor Positive Tumor

Interventions

DRUG: AZD2014
DRUG: Anastrozole

Sponsor

Centre Leon Berard